Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-3237

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-3237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Oxcarbazepine 300mg 70518 3237 01)

Mm2 (Oxcarbazepine 300mg 70518 3237 01)
OXcarbazepine is a prescription-only medicine manufactured by Glenmark in Mahwah, NJ, USA. Each pack contains a single HD2 tablet with NDC number 70518-3237-01. The expiration date and LOT number are not available. The drug should be stored at 20-26°C with excursions allowed to 15-30°C, and kept out of reach of children. Directions for use can be found in the package insert. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA, USA.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
OXcarbazepine is a prescription medication provided in a quantity of 100 HD2 pills. The package insert should be consulted for usage instructions. The medication should be stored between 20-26°C (63-77°F), with short periods at 15-30°C (59-86°F) permitted. The manufacturer is Glenmark, located in Mahwah, NJ. The medication was repackaged by RemedyRepack Inc located in Indiana, PA.*
FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.